ENPNewswire-August 20, 2019--Oncoceutics Licenses Patent from the Scripps Research Institute for Composition of Matter
This patent covers the composition of matter
of ACH-5548, and a pharmaceutical composition that includes ACH-5548, a key mediator in the complement alternative pathway.
Biopharmaceutical company Propanc Biopharma Inc (OTCQB:PPCB) revealed on Wednesday the receipt of a Notice of Allowance from the US Patent and Trademark Office (USPTO) for the composition of matter
claims involving trypsinogen and chymotryosinogen for treating cancer.
The firm's intellectual property portfolio includes a broad range of both composition of matter
and method patents.
The newly-issued composition of matter
, method, and design patents include more than 110 patents in Europe, 18 in the U.S, 14 in Japan, and 52 in other Asian/Pacific countries including China, Hong Kong, Singapore, South Korea, and Australia.
This method of use patent for Tonmya extends upon previously granted patents related to the composition of matter
Sabbah, Massalha and Saliba developed a composition of matter
consisting of anaerobic degrading microorganisms, active carbon particles and humic acid encapsulated in a porous polyurethane.
law, the patent application must be directed to one or more of a process, machine, manufacture or composition of matter
. For metalcasters, this could include a new austempered ductile iron composition, a casting made from that composition, a method of making that composition, or a novel molding machine.
AlgiSys, Cleveland, OH, has been awarded a composition of matter
patent from the U.S.
In addition to securing core composition of matter
patent rights for its antibody products, arGEN-X is pleased to announce the grant of an additional patent (US 8,835,607) relating to its SIMPLE Antibody platform technology involving broad patent claims relating to arGEN-X' germlining approach for SIMPLE Antibodies.
Next, the trusty and tough side-kick to the lead hero composition of matter
claims: the process/method claim!
Melbourne, Australia, May 24, 2011 - (ABN Newswire) - Australian regenerative medicine company, Mesoblast Limited (ASX:MSB) (PINK:MBLTY), today announced that the company's product development strategy has been significantly strengthened by novel composition of matter
claims granted by the United States Patent and Trade Mark Office (USPTO) in two distinct patent families to which Mesoblast has exclusive worldwide commercial rights.